Additional Data on Lumos OraGrowtH Trials Presented

Additional Data on Lumos OraGrowtH Trials Presented

Oral Presentation Highlighting Data on 15 Subjects from OraGrowtH212 Trial Supportive of Conclusions from Interim Data Analysis Baseline Characteristics......

Rapid Micro Biosystems to Participate in the Cowen 43rd

Rapid Micro Biosystems to Participate in the Cowen 43rd

LOWELL, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology......

Rapid Micro Biosystems to Announce Fourth Quarter and Full

Rapid Micro Biosystems to Announce Fourth Quarter and Full

LOWELL, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology......

menu
menu